Evidence map›Paper›PMID 34305583›Full record

ArticleFrontiers in pharmacology2021

Antimetastatic Effects of

Haocheng Xian, Jiayi Li, Yimeng Zhang, Ditian Li, Yinan Zhu, Siyan Li, Zhelun Tan, Zhibin Lin, Xuejun Li, Yan Pan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Effects ofFrontiers in nutrition · 2023
    Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Haocheng XianDepartment of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University and Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing, China.
Jiayi LiDepartment of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University and Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing, China.
Yimeng ZhangDepartment of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University and Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing, China.
Ditian LiDepartment of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University and Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing, China.
Yinan ZhuDepartment of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University and Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing, China.
Siyan LiDepartment of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University and Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing, China.
Zhelun TanDepartment of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University and Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing, China.
Zhibin LinDepartment of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University and Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing, China.
Xuejun LiDepartment of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University and Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing, China.
Yan PanDepartment of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University and Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing, China.
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Ganoderma lucidum polysaccharide peptidegut microbiotaproteomicssleep fragmentationtumor metastasis

Identifiers

PMID34305583
PMCPMC8296642
OpenAlexW3182817512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.